EFFECTS OF GEOMETRIC ISOMERISM AND LIGAND SUBSTITUTION IN BIFUNCTIONAL DINUCLEAR PLATINUM COMPLEXES ON BINDING-PROPERTIES AND CONFORMATIONAL-CHANGES IN DNA

被引:118
作者
FARRELL, N [1 ]
APPLETON, TG [1 ]
QU, Y [1 ]
ROBERTS, JD [1 ]
FONTES, APS [1 ]
SKOV, KA [1 ]
WU, P [1 ]
ZOU, Y [1 ]
机构
[1] BRITISH COLUMBIA CANC RES CTR,VANCOUVER,BC V5Z 1L3,CANADA
关键词
D O I
10.1021/bi00047a013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The DNA binding profile of a series of dinuclear platinum complexes [{trans-PtCl-(L)(2)}2H2N(CH2)(n)NH2](2+) (L = NH3 or py; 1,l/t,t/NH3 and 1,l/t,t/py, respectively) and [{cis-PtCl-(NH3)(2)}2H2N(CH2)(n)NH2](2+) (1,l/c,c/NH3) was examined to compare the effects of geometrical isomerism and the presence of ligands other than NH3 in the coordination sphere. Steric effects, because of the geometry of the leaving groups cis to the diamine bridge or the presence of planar pyridine ligands, result in diminished binding to calf thymus DNA for these isomers. In contrast, the pyridine derivative shows a distinct binding preference for poly(dG-dC). poly(dG-dC) in comparison to both NH3 isomers. Both NH3 complexes induce the B --> Z transition in poly(dG-dC). poly(dG-dC), but the presence of a pyridine ligand stabilizes the B conformation. The bifunctional binding of the NH3 isomers results in unwinding of supercoiled pUC19 plasmid DNA equivalent to cis-DDP, while the unwinding of the pyridine derivative is approximately twice that of the mononuclear trans-[PtCl2(py)(2)]. DNA-DNA interstrand cross-linking is very efficient for all three agents, but sequencing studies indicated that only the 1,l/t,t/NH3 derivative is capable of forming a (Pt,Pt) intrastrand cross-link to the adjacent guanines of a d(GpG) sequence. The effects on DNA caused by bifunctional binding of dinuclear complexes are compared with those from the mononuclear [PtCl2(NH3)(2)] isomers. The results are discussed with respect to the antitumor activity of the dinuclear series.
引用
收藏
页码:15480 / 15486
页数:7
相关论文
共 48 条
[1]   DNA UNWINDING PRODUCED BY SITE-SPECIFIC INTRASTRAND CROSS-LINKS OF THE ANTITUMOR DRUG CIS-DIAMMINEDICHLOROPLATINUM(II) [J].
BELLON, SF ;
COLEMAN, JH ;
LIPPARD, SJ .
BIOCHEMISTRY, 1991, 30 (32) :8026-8035
[2]   CHARACTERIZATION OF HIGH MOBILITY GROUP PROTEIN-BINDING TO CISPLATIN-DAMAGED DNA [J].
BILLINGS, PC ;
DAVIS, RJ ;
ENGELSBERG, BN ;
SKOV, KA ;
HUGHES, EN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 188 (03) :1286-1294
[3]   CISPLATIN-DNA DAMAGE RECOGNITION PROTEINS IN HUMAN TUMOR EXTRACTS [J].
BISSETT, D ;
MCLAUGHLIN, K ;
KELLAND, LR ;
BROWN, R .
BRITISH JOURNAL OF CANCER, 1993, 67 (04) :742-748
[4]   THE DINUCLEAR COMPLEX [(TRANS-PTCL(NH3)2)2(MU-H2N(CH2)6NH2)]CL2 FORMS A UNIQUE MACROCHELATE INTRASTRAND CROSS-LINK WITH D(GPG) [J].
BLOEMINK, MJ ;
REEDIJK, J ;
FARRELL, N ;
QU, Y ;
STETSENKO, AI .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1992, (14) :1002-1003
[5]   IXR1, A YEAST PROTEIN THAT BINDS TO PLATINATED DNA AND CONFERS SENSITIVITY TO CISPLATIN [J].
BROWN, SJ ;
KELLETT, PJ ;
LIPPARD, SJ .
SCIENCE, 1993, 261 (5121) :603-605
[6]   CISPLATIN-RESISTANT CELLS EXPRESS INCREASED LEVELS OF A FACTOR THAT RECOGNIZES DAMAGED DNA [J].
CHU, G ;
CHANG, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3324-3327
[7]  
CHU G, 1994, J BIOL CHEM, V269, P787
[8]   BINDING OF CIS-DICHLORODIAMMINEPLATINUM(II) AND TRANS-DICHLORODIAMMINEPLATINUM(II) TO DNA - EVIDENCE FOR UNWINDING AND SHORTENING OF THE DOUBLE HELIX [J].
COHEN, GL ;
BAUER, WR ;
BARTON, JK ;
LIPPARD, SJ .
SCIENCE, 1979, 203 (4384) :1014-1016
[9]   CONFORMATIONAL-ANALYSIS OF THE ADDUCT CIS-[PT(NH3)2(D(GPG))]+ IN AQUEOUS-SOLUTION - A HIGH-FIELD (500-300 MHZ) NUCLEAR MAGNETIC-RESONANCE INVESTIGATION [J].
DENHARTOG, JHJ ;
ALTONA, C ;
CHOTTARD, JC ;
GIRAULT, JP ;
LALLEMAND, JY ;
DELEEUW, FAAM ;
MARCELIS, ATM ;
REEDIJK, J .
NUCLEIC ACIDS RESEARCH, 1982, 10 (15) :4715-4730
[10]   NONCLASSICAL PLATINUM ANTITUMOR AGENTS - PERSPECTIVES FOR DESIGN AND DEVELOPMENT OF NEW DRUGS COMPLEMENTARY TO CISPLATIN [J].
FARRELL, N .
CANCER INVESTIGATION, 1993, 11 (05) :578-589